Study of renal diseases caused by podocyte injury

足细胞损伤所致肾脏疾病的研究

基本信息

  • 批准号:
    15209030
  • 负责人:
  • 金额:
    $ 31.53万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2005
  • 项目状态:
    已结题

项目摘要

To investigate causal relationship between podocyte injury and glomerular sclerosis, a hallmark of chronic renal failure, we developed a transgenic mouse line (NEP25) in which podocyte-selective injury can be induced by a single injection of immunotoxin (LMB2). After LMB2 injection, NEP25 mice manifested injury of podocytes and other glomerular cells and rapidly developed glomerular sclerosis. Labeling of the podocyte-lineage utilizing the Cre-loxP system revealed that following downregulation of podocyte markers, podocytes were progressively lost, without transforming into other types of cell. Studies using chimeric mice revealed that injury initiated in a portion of podocytes was spread to other podocytes, thus forming a vicious cycle of self-perpetuating injury.Using other transgenic mouse lines that we developed, we demonstrated that in the presence of FVB/N genetic background, HIV-1 genes, vpr and nef, synergistically damage podocytes, leading to collapsing FSGS similar to HIV-1 associated nephropathy of humans.In both NEP25 and HIV-1 models, damage of podocytes was prevented remarkably by ureteral obstruction, indicating that continued glomerular filtration is a prerequisite for progressive injury of podocytes, and subsequent development of glomerular sclerosis.We also studied the role of mutant α-Actinin-4, which causes autosomal dominant focal segmental glomerular sclerosis (FSGS) in humans. Transgenic mice expressing mutant α-Actinin-4 in podocytes developed slowly progressive FSGS. By crossing α-Actinin-4 with NEP25 mice, we demonstrated that mutant α-Actinin-4 attenuated glomerular damage induced by LMB2.Thus, we demonstrated that in the presence of glomerular filtration, podocyte damage induced by various factors is automatically spread to other podocytes and types of cell within the glomerulus, which leads to glomerular sclerosis.
为了研究足细胞损伤与肾小球硬化(慢性肾衰竭的标志)之间的因果关系,我们开发了一种转基因小鼠系(NEP25),其中单次注射免疫毒素(LMB2)可诱导足细胞选择性损伤。注射LMB2后,NEP25小鼠出现足细胞等肾小球细胞损伤,迅速发展为肾小球硬化。利用Cre-loxP系统对足细胞谱系进行标记显示,在足细胞标记下调后,足细胞逐渐丢失,而不会转化为其他类型的细胞。嵌合小鼠的研究表明,一部分足细胞的损伤会扩散到其他足细胞,从而形成自我延续损伤的恶性循环。利用我们开发的其他转基因小鼠系,我们证明了在FVB/N遗传背景下,HIV-1基因vpr和nef会协同损害足细胞,导致FSGS塌陷,类似于人类HIV-1相关肾病。在NEP25和HIV-1模型中,输尿管梗阻明显阻止足细胞损伤,这表明肾小球滤过的持续存在是足细胞进行性损伤和肾小球硬化的先决条件。我们还研究了突变体α- actiin -4在人类常染色体显性局灶节段性肾小球硬化(FSGS)中的作用。在足细胞中表达突变α- actiin -4的转基因小鼠发生缓慢进行性FSGS。通过α- actiin -4与NEP25小鼠杂交,我们发现α- actiin -4突变体可以减轻LMB2引起的肾小球损伤。因此,我们证明,在肾小球滤过存在的情况下,由各种因素引起的足细胞损伤会自动扩散到肾小球内的其他足细胞和细胞类型,从而导致肾小球硬化。

项目成果

期刊论文数量(42)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A role of BMP in the development of glomerular sclerosis.
BMP 在肾小球硬化发展中的作用。
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ueda H;Miyazaki Y;Yokoo T;Utsunomiya Y;Kawamura T;Matsusaka T;Ichikawa I;Hosoya T.
  • 通讯作者:
    Hosoya T.
Podocyte injury and glomerular sclerosis.
足细胞损伤和肾小球硬化。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kato J;Kohyama T;Okazaki H;Desaki M;Rennard SI;Takizawa H;Nagase T.;Matsusaka T.
  • 通讯作者:
    Matsusaka T.
Podocyte biology, insights from knock-out and transgenic mouse studies
足细胞生物学,基因敲除和转基因小鼠研究的见解
  • DOI:
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Takai D;Nagase T;Shimizu T;Matsusaka T.
  • 通讯作者:
    Matsusaka T.
J Zhong, A Fogo, I Ichikawa, T Matsusaka: "Role of Angiotensin II the Development of Focal Segmental Glomerulosclerosis (FSGS) in Human Immunodeficiency Virus (HIV)-1 Associated Nephropathy (HIVAN)."J Am Soc Nephrol (abstract). 14. 153A (2003)
J Chung、A Fogo、I Ichikawa、T Matsusaka:“血管紧张素 II 在人类免疫缺陷病毒 (HIV)-1 相关肾病 (HIVAN) 中局灶节段性肾小球硬化 (FSGS) 发展中的作用。”J Am Soc Nephrol(摘要)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
J Zhong, Y Zuo, J Ma, A Fogo, I Ichikawa, T Matsusaka: "Expression of HIV-1 Genes in Podocytes Alone Can Lead to Glomerulosclerosis."J Am Soc Nephrol (abstract). 14. 153A (2003)
J Chung、Y Zuo、J Ma、A Fogo、I Ichikawa、T Matsusaka:“足细胞中 HIV-1 基因的单独表达可导致肾小球硬化。”J Am Soc Nephrol(摘要)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MATSUSAKA Taiji其他文献

MATSUSAKA Taiji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MATSUSAKA Taiji', 18)}}的其他基金

High-throughput verification of pathways regulating kidney diseases
肾脏疾病调节途径的高通量验证
  • 批准号:
    19K22628
  • 财政年份:
    2019
  • 资助金额:
    $ 31.53万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Next generation therapy of podocytopathy developed by renal organoid
肾类器官开发的下一代足细胞病疗法
  • 批准号:
    18H02827
  • 财政年份:
    2018
  • 资助金额:
    $ 31.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mechanisms of progression of chronic kidney disease
慢性肾脏病的进展机制
  • 批准号:
    22249033
  • 财政年份:
    2010
  • 资助金额:
    $ 31.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Mechanism of podocyte injury
足细胞损伤机制
  • 批准号:
    18209030
  • 财政年份:
    2006
  • 资助金额:
    $ 31.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
In vivo analysis of the regulation of renin production
肾素产生调节的体内分析
  • 批准号:
    12470212
  • 财政年份:
    2000
  • 资助金额:
    $ 31.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Studies on mitochondrial function of podocyte, and its role for proteinuria and glomerular sclerosis.
足细胞线粒体功能及其在蛋白尿和肾小球硬化中的作用研究。
  • 批准号:
    18590879
  • 财政年份:
    2006
  • 资助金额:
    $ 31.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
glomerular sclerosis
肾小球硬化
  • 批准号:
    16109005
  • 财政年份:
    2004
  • 资助金额:
    $ 31.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Mechanism of Initiation and Progression of Glomerular Sclerosis and its Prevention in Hypertensive Kidneys
高血压肾病肾小球硬化的发生、进展机制及防治
  • 批准号:
    10670998
  • 财政年份:
    1998
  • 资助金额:
    $ 31.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ACTION OF LOVASTATIN IN PATIENTS WITH FOCAL SEGMENTAL GLOMERULAR SCLEROSIS
洛伐他汀对局灶节段性肾小球硬化症患者的作用
  • 批准号:
    6244189
  • 财政年份:
    1997
  • 资助金额:
    $ 31.53万
  • 项目类别:
Regulation loss of mesangial cell function leading to irreversible, glomerular sclerosis.
系膜细胞功能调节丧失导致不可逆的肾小球硬化。
  • 批准号:
    06670215
  • 财政年份:
    1994
  • 资助金额:
    $ 31.53万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
PATTERNS OF MATRIX SYNTHESIS IN GLOMERULAR SCLEROSIS
肾小球硬化症中基质合成的模式
  • 批准号:
    2133999
  • 财政年份:
    1993
  • 资助金额:
    $ 31.53万
  • 项目类别:
ETIOLOGIC FACTORS IN FOCAL GLOMERULAR SCLEROSIS
局灶性肾小球硬化的病因
  • 批准号:
    3245224
  • 财政年份:
    1993
  • 资助金额:
    $ 31.53万
  • 项目类别:
ETIOLOGIC FACTORS IN FOCAL GLOMERULAR SCLEROSIS
局灶性肾小球硬化的病因
  • 批准号:
    2143254
  • 财政年份:
    1993
  • 资助金额:
    $ 31.53万
  • 项目类别:
ETIOLOGIC FACTORS IN FOCAL GLOMERULAR SCLEROSIS
局灶性肾小球硬化的病因
  • 批准号:
    2143253
  • 财政年份:
    1993
  • 资助金额:
    $ 31.53万
  • 项目类别:
PATTERNS OF MATRIX SYNTHESIS IN GLOMERULAR SCLEROSIS
肾小球硬化症中基质合成的模式
  • 批准号:
    3081111
  • 财政年份:
    1993
  • 资助金额:
    $ 31.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了